The new respiratory virus 2023 has been causing chaos especially the a lot of people acquiring and getting sick because of it. inline with this matter, FDA has released available vaccines that are ready to be given to people.
Respiratory Syncytial Virus or RSV cases are on a rise, FDA-approved vaccines are on the way to help with such illness. (Photo: Health)
New Respiratory Virus 2023
The new respiratory virus 2023 has now multiple cases around the world. The new respiratory virus 2023 or Respiratory Syncytial Virus is now causing havoc among people of weak immune systems.
The new respiratory virus 2023 has now compromised a lot of individuals. With memories of COVID-19 still fresh from the people’s minds, the new respiratory virus 2023 just adds to the list of illnesses to be worried about.
Although safety measure are a lot better for this new respiratory virus 2023, it could still be a root for more serious illnesses. It is said that when a person acquires this new respiratory virus 2023, it could compromise other body organs.
According to a published article by Healthline, due to the new respiratory virus 2023’s worrisome effects to the body, vaccines are set to be made and distributed. These FDA-approved vaccine are set to be given for those at higher risks of contracting the new respiratory virus 2023.
Two FDA-Approved Vaccines For RSV
In a published article by American Pharmacists Association, FDA has approved two vaccines for RSV. Arexvy and Abrysvo are FDA-approved vaccines in order to prevent more fatal effects of the RSV. These FDA-approved vaccines has somewhat the same after effects of the COVID vaccine, such as pain in the injection site as well as headaches.
READ ALSO: The Combination Of Unusual Eating And Sleeping Habits Affect Heart Health According To Study
